NOVAMEDIX

Welcome to the Brand page for “NOVAMEDIX”, which is offered here for Medical apparatus, an ex vivo anatomical pump, impulse generator and controls therefor, sold as a unit and used for the following; the reduction of post operative and post traumatic pain and swelling; for the reduction of compartmental pressures to avoid fasciotomy and associated complications; for pre-operative and post-operative prohylaxis of deep vein thrombosis; for the treatment of sudeck's syndrome (reflex sympathetic dystrophy); for maintaining patency and reducing edema in high-risk limb bypass grafts, i.e. femorodistal tibial graft; for a reduction in rest pain and maintenance of circulation in patients awaiting surgery; for the stimulation of circulation in peripheral vascular disease in the critically ischaemic limb to maintain limb viability; for the treatment of exacerbations of raynaud's disease; for the stimulation of circulation in patients at risk of developing ischaemic ulceration (diabetes, etc.); for the enhancement of blood supply prior to grafting; and for the treatment of venous ulceration and in the avoidance of recurrence;.

Its status is currently believed to be active. Its class is unavailable. “NOVAMEDIX” is believed to be currently owned by “CARDINAL HEALTH IRELAND UNLIMITED COMPANY”.


Owner:
CARDINAL HEALTH IRELAND UNLIMITED COMPANY
Owner Details
Description:
MEDICAL APPARATUS, AN EX VIVO ANATOMICAL PUMP, IMPULSE GENERATOR AND CONTROLS THEREFOR, SOLD AS A UNIT AND USED FOR THE FOLLOWING; THE REDUCTION OF POST OPERATIVE AND POST TRAUMATIC PAIN AND SWELLING; FOR THE REDUCTION OF COMPARTMENTAL PRESSURES TO AVOID FASCIOTOMY AND ASSOCIATED COMPLICATIONS; FOR PRE-OPERATIVE AND POST-OPERATIVE PROHYLAXIS OF DEEP VEIN THROMBOSIS; FOR THE TREATMENT OF SUDECK'S SYNDROME (REFLEX SYMPATHETIC DYSTROPHY); FOR MAINTAINING PATENCY AND REDUCING EDEMA IN HIGH-RISK LIMB BYPASS GRAFTS, I.E. FEMORODISTAL TIBIAL GRAFT; FOR A REDUCTION IN REST PAIN AND MAINTENANCE OF CIRCULATION IN PATIENTS AWAITING SURGERY; FOR THE STIMULATION OF CIRCULATION IN PERIPHERAL VASCULAR DISEASE IN THE CRITICALLY ISCHAEMIC LIMB TO MAINTAIN LIMB VIABILITY; FOR THE TREATMENT OF EXACERBATIONS OF RAYNAUD'S DISEASE; FOR THE STIMULATION OF CIRCULATION IN PATIENTS AT RISK OF DEVELOPING ISCHAEMIC ULCERATION (DIABETES, ETC.); FOR THE ENHANCEMENT OF BLOOD SUPPLY PRIOR TO GRAFTING; AND FOR THE TREATMENT OF VENOUS ULCERATION AND IN THE AVOIDANCE OF RECURRENCE;
Categories: MEDICAL APPARATUS